000 02426cam a2200349 a 4500
003 EG-GiCUC
005 20250223031733.0
008 170614s2016 ua h f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.31.M.Sc.2016.Na.D
100 0 _aNada Mohsen Salama Mohamed
245 1 0 _aDiffusion weighted imaging versus Subtraction MRI in assessing treatment response of hepatocellular carcinoma after trans-arterial chemoembolization (TACE) /
_cNada Mohsen Salama Mohamed ; Supervised Ikram Hamed Mahmoud , Noha Abdelshafy Elsaid , Marwa Shaker Abdelfattah
246 1 5 _aمقارنة دور التصو{u٠٦أأ}ر بالرن{u٠٦أأ}ن المغناط{u٠٦أأ}سي الإنتشاري الموزون مع الرن{u٠٦أأ}ن المغناط{u٠٦أأ}سي بالصبغة مع الطرح في تق{u٠٦أأ}{u٠٦أأ}م كفاءة علاج سرطان الكبد الأولى بعد الحقن الشر{u٠٦أأ}انى الك{u٠٦أأ}مائى
260 _aCairo :
_bNada Mohsen Salama Mohamed ,
_c2016
300 _a167 P. :
_bfacsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Radio-diagnosis
520 _aTrans arterial chemoembolization is a locoregional ablative proceadure commonly used for non resectable hepatocellular carcinomas.Selective embolization of tumor vessels with chemotherapeutic agents reduces tumoral blood flow and prolongs its contact with the chemotherapeutic agents. However, enhancement on DCE-MRI post TACE represents either residual tumoral tissue mixed with necrotic regions or granulation tissue. Aim of the study : Further tools additive tools are needed as DWI and subtracted DCE-MRI to assess tumour viability and need for futher TACE sessions. Our aim is to evaluate the specificity , sensitivity and assign a confidence level for readers using both techniques
530 _aIssued also as CD
653 4 _aDiffusion weighted MRI
653 4 _aSubtraction dynamic MRI
653 4 _aTrans-arterial chemoembolization (TACE)
700 0 _aIkram Hamed Mahmoud ,
_eSupervisor
700 0 _aMarwa Shaker Abdelfattah ,
_eSupervisor
700 0 _aNoha Abdelshafy Elsaid ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c61229
_d61229